Stock LLY ELI LILLY AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Eli Lilly and Company

Equities

LLY

US5324571083

Market Closed - Nyse
Other stock markets
 21:00:02 13/09/2024 BST 		5-day change 1st Jan Change
923.71 USD -1.21% Intraday chart for Eli Lilly and Company +2.33% +58.46%
09-13 Eli Lilly Gets FDA Approval for Eczema Treatment Ebglyss DJ
09-13 Eli Lilly Gets US FDA Approval for Atopic Dermatitis Treatment MT

Chart calendar Eli Lilly and Company

ee1a9e.hVKWVYulMfD3g5GHjJxXlu5RIB9-UGKwcWFJq2Hnwz4.8h7cDeXEQcGUx9uyxNow4KEAWGYaZjbROVYR6BfVolTLBediwfVHv7HuwA~42cd8c60da6b547da5baca7e121befc4

Upcoming events on Eli Lilly and Company

30/10/2024 10:25 Q3 2024 Earnings Release
30/10/2024 14:00 Q3 2024 Earnings Call
02/11/2024 ObesityWeek Conference
29/01/2025 Q4 2024 Earnings Release (Projected)
23/04/2025 Q1 2025 Earnings Release (Projected)
04/08/2025 Q2 2025 Earnings Release (Projected)
03/11/2025 Q3 2025 Earnings Release (Projected)

Past events on Eli Lilly and Company

09/09/2024 European Association for the Study of Diabetes Meeting
05/09/2024 12:45 Morgan Stanley Healthcare Conference
14/08/2024 Détachement de
08/08/2024 15:00 Q2 2024 Earnings Call
08/08/2024 11:45 Q2 2024 Earnings Release
21/06/2024 20:45 American Diabetes Association Scientific Symposium
10/06/2024 21:00 Goldman Sachs Global Healthcare Conference - Fireside Chat
03/06/2024 23:12 American Society of Clinical Oncology Meeting - Abstract Number: LBA507
03/06/2024 19:30 American Society of Clinical Oncology Meeting - Abstract Number: 8547
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract Number: 5589
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract Number: 11111
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract Number: 11068
03/06/2024 01:30 American Society of Clinical Oncology Meeting
02/06/2024 23:06 American Society of Clinical Oncology Meeting - Abstract Number: 10022
02/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract Number: 1027
01/06/2024 23:00 American Society of Clinical Oncology Meeting - Abstract Number: 3007
01/06/2024 21:12 American Society of Clinical Oncology Meeting - Abstract Number: 5001
01/06/2024 21:00 American Society of Clinical Oncology Meeting - Abstract Number: LBA1001
01/06/2024 19:39 American Society of Clinical Oncology Meeting - Abstract Number: 8510
01/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract Number: 3150

Past dividends on Eli Lilly and Company

14/08/2024 Quarterly 1.3 USD
14/05/2024 Quarterly 1.3 USD
13/02/2024 Quarterly 1.3 USD
13/11/2023 Quarterly 1.13 USD
13/08/2023 Quarterly 1.13 USD
11/05/2023 Quarterly 1.13 USD
13/02/2023 Quarterly 1.13 USD
13/11/2022 Quarterly 0.98 USD
11/08/2022 Quarterly 0.98 USD
12/05/2022 Quarterly 0.98 USD
13/02/2022 Quarterly 0.98 USD
11/11/2021 Quarterly 0.85 USD
11/08/2021 Quarterly 0.85 USD
12/05/2021 Quarterly 0.85 USD
10/02/2021 Quarterly 0.85 USD
11/11/2020 Quarterly 0.74 USD
12/08/2020 Quarterly 0.74 USD
13/05/2020 Quarterly 0.74 USD
12/02/2020 Quarterly 0.74 USD
13/11/2019 Quarterly 0.645 USD

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million USD		Released
Forecast
Spread 		28 318
28 205
0.4%		28 541
28 641
-0.35%		34 124
33 585
1.6%
46 251


57 467


68 497

EBITDA
Million USD		Released
Forecast
Spread 		10 005
9 767
2.43%		9 473
9 494
-0.23%		8 584
8 418
1.98%
19 019


25 670


32 688

EBIT
Million USD		Released
Forecast
Spread 		8 457
8 599
-1.65%		7 950
8 164
-2.62%		7 057
6 928
1.86%
17 544


23 621


30 336

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		6 156
7 148
-13.88%		6 806
7 084
-3.93%		6 555
6 311
3.86%
16 290


18 903


23 484

Net income
Million USD		Released
Forecast
Spread 		5 582
6 019
-7.27%		6 245
6 102
2.35%		5 240
5 307
-1.26%
13 932


18 897


24 547

EPS
USD		Released
Forecast
Spread 		6,12
6,43
-4.75%		6,90
6,60
4.57%		5,80
6,04
-3.92%
15,5


21,2


27,2

Announcement Date03/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodGiugno 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD		Released
Forecast
Spread 		6 942
6 901
0.58%		7 302
7 376
-1%		6 960
6 867
1.36%		8 312
7 590
9.51%		9 499
8 965
5.96%		9 353
8 971
4.27%		8 768
8 930
-1.81%		11 303
9 968
13.4%
12 013


13 569


13 500


13 535


14 215


15 320

EBITDA
Million USD		Released
Forecast
Spread 		2 373
2 385
-0.5%		2 375
2 268
4.72%		1 982
2 148
-7.73%		2 618
2 416
8.39%		986
3 460
-71.49%		2 855
3 517
-18.81%		3 049
2 827
7.84%		4 268
3 848
10.91%
5 906


7 307













EBIT
Million USD		Released
Forecast
Spread 		2 010
2 007
0.13%		2 000
1 953
2.41%		1 620
1 840
-11.95%		2 252
2 078
8.37%		575
921
-37.56%		2 468
2 448
0.79%		2 648
2 674
-0.96%		3 854
3 028
27.27%
4 783


5 878













Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread








2 089
2 107
-0.86%		427
-399
207.07%		2 509
1 248
101.03%		2 536
2 455
3.3%		3 517
3 065
14.75%
4 757


5 475













Net income
Million USD		Released
Forecast
Spread 		1 452
1 453
-0.09%		1 938
1 681
15.27%		1 345
1 544
-12.9%		1 763
1 660
6.22%		-57,4
-813
92.94%		2 190
1 811
20.89%		2 243
2 058
8.99%		2 967
2 415
22.87%
4 032


4 771













EPS
USD		Released
Forecast
Spread 		1,61
1,90
-15.26%		2,14
1,78
20.22%		1,49
2,04
-26.96%		1,95
1,81
7.73%		-0,06
-0,66
90.91%		2,42
2,26
7%		2,48
2,44
1.64%		3,28
2,72
20.64%
4,52


5,14













Announcement Date01/11/2202/02/2327/04/2308/08/2302/11/2306/02/2430/04/2408/08/24------

Upcoming sector events for Eli Lilly and Company

02/10/2024 TILRAY BRANDS, INC.: Q1 2025 Earnings Release (Projected)
09/10/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q2 2025 Earnings Release
09/10/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q2 2024 Earnings Release
10/10/2024 06:00 FAGRON N.V.: Q3 2024 Sales and Revenue Release - Trading Update
15/10/2024 11:45 JOHNSON & JOHNSON: Q3 2024 Earnings Release
15/10/2024 SSY GROUP LIMITED: Q3 2024 Earnings Release (Projected)
15/10/2024 GUOBANG PHARMA LTD.: Q3 2024 Earnings Release (Projected)
17/10/2024 GLENMARK LIFE SCIENCES LIMITED: Q2 2025 Earnings Release (Projected)
17/10/2024 SHANDONG WIT DYNE HEALTH CO.,LTD.: Q3 2024 Earnings Release (Projected)
17/10/2024 CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD.: Q3 2024 Earnings Release (Projected)
More events

Past sector events for Eli Lilly and Company

10/09/2024 09:14 LOTUS PHARMACEUTICAL CO., LTD.: August 2024 Sales and Revenue Release
08/09/2024 PHARMANUTRA S.P.A.: Q2 2024 Earnings Release
30/08/2024 ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q2 2024 Earnings Release
30/08/2024 HUAPONT LIFE SCIENCES CO.,LTD.: Q2 2024 Earnings Release
30/08/2024 WEDGE INDUSTRIAL CO.,LTD.: Q2 2024 Earnings Release
30/08/2024 JILIN AODONG PHARMACEUTICAL GROUP CO., LTD.: Q2 2024 Earnings Release
30/08/2024 ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.: Q2 2024 Earnings Release
30/08/2024 BEIJING TONGRENTANG CO., LTD: Q2 2024 Earnings Release
30/08/2024 GUANGXI WUZHOU ZHONGHENG GROUP CO.,LTD: Q2 2024 Earnings Release
30/08/2024 JINYU BIO-TECHNOLOGY CO., LTD.: Q2 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. Calendar Eli Lilly and Company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition